Navigation Links
BeneChill's RhinoChill System Receives CE Marking for European Commercial Sale

SAN DIEGO, Jan. 15 /PRNewswire/ -- BeneChill, Inc., today announced it has received CE Marking for the commercial sale of the RhinoChill System in European Union member countries. The RhinoChill System is a battery-operated, non-invasive, portable, and easy-to-use medical device for rapid therapeutic patient cooling.


"This is an important step for BeneChill," said Denise Barbut, MD, who is founder and CEO of BeneChill. "We've spent the past three years developing RhinoChill. Clinical trials in Europe and elsewhere have demonstrated that RhinoChill decreases temperature in patients requiring cooling therapy. We are very pleased with this market clearance, which will provide medical personnel within the European Union with a user-friendly tool to cool patients rapidly and non-invasively."

The RhinoChill System uses a nasal catheter to deliver a proprietary inert coolant to the nasal cavity to reduce patient temperature. Therapeutic hypothermia (reducing patient temperature to approximately 33 degrees C or 91 degrees F) has been shown to improve survival and neurologic outcome after cardiac arrest. The American Heart Association and the International Liaison Committee on Resuscitation recommend the use of therapeutic hypothermia in comatose survivors of cardiac arrest. Other possible uses of therapeutic hypothermia include stroke and traumatic brain injury.

The RhinoChill System is designed to overcome limitations of other temperature reduction technologies by enabling early and rapid initiation of patient cooling. The battery-operated RhinoChill System does not require a refrigeration unit -- a drawback associated with all existing hypothermia devices.

"RhinoChill is a unique approach to patient cooling," stated BeneChill COO Allan Rozenberg, PhD, at today's announcement. "RhinoChill uses the nasal cavity, which is the body's natural heat exchanger and is in close proximity to the brain."

Dr. Rozenberg also noted that using the nasal cavity enables treatment by non-specialized medical personnel using non-sterile technique in any surrounding, including ambulances, military rescue operations and emergency rooms, as well as general hospital environments.

About BeneChill:

BeneChill is a venture capital funded medical device company based in San Diego, CA. The company is developing products in the therapeutic hypothermia arena with a focus on rapid and non-invasive cooling in the field. The technology has been used in Europe in cardiac arrest patients. For more information about BeneChill, please visit

The RhinoChill System is an investigational device in the United States. The device is limited by United States law to investigational use only.

SOURCE BeneChill, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Different method of evaluating the urinary tract system reduces radiation dose
2. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
3. Exempla Healthcare Contracts For Talismans Quality Donor System
4. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
5. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
6. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
7. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
8. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
11. NAMSA Deploys TrackWise Software as its Quality Management System
Post Your Comments:
(Date:11/28/2015)... PA (PRWEB) , ... November 28, 2015 , ... Safe ... the creativity of two inventors, one from Lakewood, New Jersey and the other from ... developed the patent-pending PROTECTOR to save the expense of having to replace NuvaRings more ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... meeting in Washington D.C. revolved around the fact that proper dental care, both at-home ... stressed the link between periodontal disease (more commonly referred to as gum disease) and ...
(Date:11/27/2015)... ... November 27, 2015 , ... An ... way to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC ... and dispense prescription medications. In doing so, it could help to prevent potential ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... innovative online platform for mental health and wellness consultation, has collaborated with a ... will bridge the knowledge gap experienced by parents and bring advice from parenting ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology: